Bharat Biotech starts phase III trials for Covaxin

Bharat Biotech has recently announced the commencement of phase III trials of the COVID-19 vaccine, Covaxin.

It will be the largest clinical trial conducted for a COVID-19 vaccine in India.

The phase III trials will involve 26,000 volunteers across 25 centres in India, being conducted in partnership with ICMR.


Leave a Reply

Your email address will not be published. Required fields are marked *

Our YouTube ChannelOur Facebook PageOur Twitter PageOur LinkedIn PageOur Instagram PageOur Whatsapp NumberYour Idea